The 20 th Essential Medicines List, published on 6 June 2017, marks the 40th anniversary of this flagship WHO tool to expand access to medicines. The updated list adds 30 medicines for adults and 25 for children, and specifies new uses for 9 already-listed products, bringing the total to 433 drugs deemed essential for addressing the most important public health needs globally. The 20 th List also provides new advice on which antibiotics to use for common infections and which to preserve for the most serious syndromes, based on a thorough review of all essential antibiotics. The aim is to optimise antibiotic use and reduce antibiotic resistance without restricting access. Other important additions include medicines for HIV, hepatitis C, tuberculosis and cancer.
A number of countries and foundations today pledged EUR million to help develop new treatments to fight against antibiotic resistance at a fundraising event for the Global Antibiotic Research and Development Partnership (GARDP). The meeting was hosted in Berlin by the German Federal Ministry of Health and the German Federal Ministry of Education and Research. GARDP was established in May 2016 as a non-profit research and development initiative by the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi). Funding will support GARDP’s four programme areas.